Direxion Daily Real Estate Bull 3X Shares ETF
DRN
Direxion Daily Energy Bull 2X Shares ETF
ERX
VanEck Oil Services ETF
OIH
4
ProShares Ultra Real Estate
URE
5
iShares US Telecommunications ETF
IYZ
US Stock MarketDetailed Quotes
Unicycive Therapeutics (UNCY)
- 6.840
- +0.130+1.94%
Close Feb 26 16:00 ET
- 6.840
- 0.0000.00%
Post 16:23 ET
147.00MMarket Cap-4.27P/E (TTM)
6.875High6.530Low405.87KVolume6.750Open6.710Prev Close2.74MTurnover2.27%Turnover RatioLossP/E (Static)21.49MShares11.00052wk High3.92P/B122.43MFloat Cap3.71052wk Low--Dividend TTM17.90MShs Float87.300Historical High--Div Yield TTM5.14%Range %2.020Historical Low6.744Avg Price1Lot Size
UNCY Stock Chart
Full Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
UNCY Orderflow
Unit: --
UNCY Orderflow Trend
IntradayDayWeekMonth
No Data
Unicycive Therapeutics (UNCY) News
Unicycive Therapeutics Management to Meet With Piper Sandler
Unicycive Therapeutics Initiated With a Buy at WestPark Capital
Analysts Offer Insights on Healthcare Companies: Protagonist Therapeutics (PTGX) and Unicycive Therapeutics (UNCY)
Guggenheim Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Maintains Target Price $46
Noble Financial Maintains Unicycive Therapeutics(UNCY.US) With Buy Rating, Raises Target Price to $60
Analysts Offer Insights on Healthcare Companies: Thermo Fisher (TMO), Phibro Animal Health (PAHC) and Unicycive Therapeutics (UNCY)
Unicycive Therapeutics (UNCY) Stock Forum
3
$Unicycive Therapeutics (UNCY.US)$ Don't Panic. Hold. Many short-term holders are now gone.
This is necessary before any sustainable rebound. Institutions / smarter money are probing, not running. If there is a strong price rebound, short sellers will scramble to cover their position.
This is necessary before any sustainable rebound. Institutions / smarter money are probing, not running. If there is a strong price rebound, short sellers will scramble to cover their position.
4
$Unicycive Therapeutics (UNCY.US)$ still low volume despite good news
1
1
$Unicycive Therapeutics (UNCY.US)$ Reuters
just
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (Olc) New Drug Application (Nda) Resubmission
just
Unicycive Therapeutics Announces FDA Acceptance of Oxylanthanum Carbonate (Olc) New Drug Application (Nda) Resubmission
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)